Marco A. De León-Nava

Dr. Marco A. De León-Nava


Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2004 in Journal of Parasitology
Verified
Journal Article
Closed access
JMJ. Morales-Montor
J. Morales-Montor
ACAnahi Chavarria
Anahi Chavarria
MLMarco A. De León-Nava
Marco A. De León-Nava
LCL. I. Del Castillo
L. I. Del Castillo
EEE. G. Escobedo
E. G. Escobedo
CLC. Larralde
C. Larralde
A review of current literature on mammalian hosts' sexual dimorphism (SD) in parasitic infections revealed that (1) it is a scarcely and superficially studied biological phenomenon of considerable significance for individual health, behavior, and lifestyles and for the evolution of species; (2) there are many notable exceptions to the rule of a favorable female bias in susceptibility to infection; (3) a complex network of molecular and cellular reactions connecting the host's immuno-neuroendocrine systems with those of the parasite is responsible for the host-parasite relationship rather than just an adaptive immune response and sex hormones; (4) a lack of gender-specific immune profiles in response to different infections; (5) the direct effects of the host hormones on parasite physiology may significantly contribute to SD in parasitism; and (6) the need to enrich the reductionist approach to complex biological issues, like SD, with more penetrating approaches to the study of cause-effect relationships, i.e., network theory. The review concludes by advising against generalization regarding SD and parasitism and by pointing to some of the most promising lines of research.

14 February 2022 in Microorganisms
Verified
Journal Article
Open access
PDF file
LMLucia Mendez
Lucia Mendez
NBNallely Bueno-Hernández
Nallely Bueno-Hernández
MCMiguel A. Cid-Soto
Miguel A. Cid-Soto
KLKaren L. De León
Karen L. De León
Viridiana Montsserrat Mendoza-MartínezViridiana Montsserrat Mendoza-Martínez
Viridiana Montsserrat Mendoza-Martínez
GEGalileo Escobedo
Galileo Escobedo
Sucralose consumption alters microbiome and carbohydrate metabolism in mouse models. However, there are no conclusive studies in humans. Our goals were to examine the effect of sucralose consumption on the intestinal abundance of bacterial species belonging to Actinobacteria, Bacteroidetes, and Firmicutes and explore potential associations between microbiome profiles and glucose and insulin blood levels in healthy young adults. In this open-label clinical trial, volunteers randomly drank water, as a control (n = 20), or 48 mg sucralose (n = 20), every day for ten weeks. At the beginning and the end of the study, participants were subjected to an oral glucose tolerance test (OGTT) to measure serum glucose and insulin every 15 min for 3 h and provided fecal samples to assess gut microbiota using a quantitative polymerase chain reaction. Sucralose intake altered the abundance of Firmicutes without affecting Actinobacteria or Bacteroidetes. Two-way ANOVA revealed that volunteers drinking sucralose for ten weeks showed a 3-fold increase in Blautia coccoides and a 0.66-fold decrease in Lactobacillus acidophilus compared to the controls. Sucralose consumption increased serum insulin and the area under the glucose curve compared to water. Long-term sucralose ingestion induces gut dysbiosis associated with altered insulin and glucose levels during an OGTT.

27 November 2008 in The Journal of Steroid Biochemistry and Molecular Biology
Verified
Journal Article
Closed access
MLMarco A. De León-Nava
Marco A. De León-Nava
KNKaren Nava
Karen Nava
GSGloria Soldevila
Gloria Soldevila
LLLorena López-Griego
Lorena López-Griego
JCJesús Chávez-Rios
Jesús Chávez-Rios
Jorge Morales-MontorJorge Morales-Montor
Jorge Morales-Montor

1 January 2013 in Mediators of Inflammation
Verified
Journal Article
Open access
PDF file
KSK. Suárez-Álvarez
K. Suárez-Álvarez
LSL. Solís-Lozano
L. Solís-Lozano
SONIA LEON-CABRERASONIA LEON-CABRERA
SONIA LEON-CABRERA
AGA. González-Chávez
A. González-Chávez
GGG. Gómez-Hernández
G. Gómez-Hernández
GEGalileo Escobedo
Galileo Escobedo
Interleukin-(IL-) 12 has been recently suggested to participate during development of insulin resistance in obese mice. Nevertheless, serum IL-12 levels have not been accurately determined in overweight and obese humans. We thus studied serum concentrations of IL-12 in Mexican adult individuals, examining their relationship with low-grade inflammation and obesity-related parameters. A total of 147 healthy individuals, 43 normal weight, 61 overweight, and 43 obese subjects participated in the study. Circulating levels of IL-12, tumor necrosis factor-alpha (TNF-α), leptin, insulin, glucose, total cholesterol, and triglyceride were measured after overnight fasting in all of the study subjects. Waist circumference and body fat percentage were recorded for all the participants. Serum IL-12 was significantly higher in overweight and obese individuals than in normal weight controls. Besides being strongly related with body mass index (r=0.5154), serum IL-12 exhibited a significant relationship with abdominal obesity (r=0.4481), body fat percentage (r=0.5625), serum glucose (r=0.3158), triglyceride (r=0.3714), and TNF-α(r=0.4717). Thus, serum levels of IL-12 are increased in overweight and obese individuals and show a strong relationship with markers of low-grade inflammation and obesity in the Mexican adult population. Further research is needed to understand the role of IL-12 in developing obesity-associated alterations in humans.

1 March 2005 in Microbes and Infection
Verified
Journal Article
Closed access
JVJosé A. Vargas-Villavicencio
José A. Vargas-Villavicencio
CLCarlos Larralde
Carlos Larralde
MLMarco A. De León-Nava
Marco A. De León-Nava
JMJorge Morales-Montor
Jorge Morales-Montor

8 April 2016 in Marine Drugs
Verified
Journal Article
Open access
PDF file
MLMarco A. De León-Nava
Marco A. De León-Nava
EREunice Romero
Eunice Romero
ALAngélica Luna-Nophal
Angélica Luna-Nophal
JBJohanna Bernaldez
Johanna Bernaldez
LCL. Noemi Sanchez Campos
L. Noemi Sanchez Campos
SMSae Muñiz-Hernández
Sae Muñiz-Hernández
Toxins that are secreted by cone snails are small peptides that are used to treat several diseases. However, their effects on parasites with human and veterinary significance are unknown. Toxoplasma gondii is an opportunistic parasite that affects approximately 30% of the world’s population and can be lethal in immunologically compromised individuals. The conventional treatment for this parasitic infection has remained the same since the 1950s, and its efficacy is limited to the acute phase of infection. These findings have necessitated the search for new drugs that specifically target T. gondii. We examined the effects of the synthetic toxin cal14.1a (s-cal14.1a) from C. californicus on the tachyzoite form of T. gondii. Our results indicate that, at micromolar concentrations, s-cal14.1a lowers viability and inhibits host cell invasion (by 50% and 61%, respectively) on exposure to extracellular parasites. Further, intracellular replication decreased significantly while viability of the host cell was unaffected. Our study is the first report on the antiparasitic activity of a synthetic toxin of C. californicus.